Smoking%20cessation Treatment

Treatment

Supportive Therapy

There is not enough evidence to support the use of alternative non-pharmacological treatments (eg acupuncture, exercise, hypnotherapy, nutritional supplements) for smoking cessation
Electronic cigarettes (e-cigarettes)
- A device similar to a real cigarette that produces a vapor which does not contain tar and other chemicals found in normal cigarettes and makes use of a replaceable cartridge containing flavoring, additives and sometimes nicotine
- Though recent evidence suggests it may be of help in quitting smoking, data regarding its efficacy and safety are insufficient; the US Preventive Services Task Force (USPSTF), the American Heart Association (AHA), the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) suggest that clinicians focus more on proven current pharmacotherapeutic agents and interventions

Prof. Ghassan Dbaibo, 27 Apr 2023

The WHO defines long COVID as a condition that occurs 3 months from COVID-19 onset, whose symptoms last ≥2 months and cannot be attributed to an alternative diagnosis. In an interview with MIMS Doctor, Professor Ghassan Dbaibo of the Center for Infectious Diseases, American University of Beirut, Beirut, Lebanon, describes the evolving attitudes towards long COVID among healthcare professionals (HCPs), some unexpected predisposing factors, potential biological mechanisms behind prolonged symptom duration and shares data on vaccination’s protective effects against long COVID.

Antigen rapid test vs RT-PCR for COVID-19: What you need to know

Pearl Toh, 29 Jul 2021

While RT-PCR is the current gold standard to confirm a SARS-CoV-2 infection, antigen rapid test (ART) for COVID-19 allows for quick detection of SARS-CoV-2 and thus fast triaging of infected patients requiring isolation at the population level, according to studies presented at ECCMID 2021.

Tackling multidrug-resistant gram-negative bacterial infections in critically ill patients: Challenging the standard approach

Dr. Asok Kurup, Dr. Kenneth Chan, 07 Dec 2020

The rising incidence of infections caused by multidrug-resistant (MDR) gram-negative bacteria has become a serious health threat and a major challenge for intensivists. Against a backdrop of high patient mortality and risk factors for infection in intensive care units (ICU), early adequate therapy is of paramount importance. At a recent Pfizer-sponsored symposium, Dr Asok Kurup, Infectious Disease Physician, Singapore presented the implications of MDR gram-negative infections in critically ill patients in Asia, while Dr Kenneth Chan, Respiratory Physician and Intensivist, Singapore highlighted the role of ceftazidime-avibactam (Zavicefta) and shared published real-world data on ceftazidime-avibactam.